Research Program Evaluation Training About Us
  
Projects & Publications
  
  

Publications: Co-Occurring Disorders


  • Lipsky S, Caetano R, Roy-Byrne P: Triple jeopardy: impact of partner violence perpetration, mental health and substance abuse on perceived unmet need for mental health care among men. Soc Psych and Psychiatri Epidemiol. (In Press).
  • Scott JD, Wang CC, Coppel E, Lau A, Veitengruber J, Roy-Byrne P: Diagnosis of depression in former injection drug users with hepatitis C. J Clin Gastroenterol, 45:462-467, 2011.
  • Lipsky, S., Krupski, A., Roy-Byrne, P., Lucenko, B., Mancuso, D., & Huber, A. (2010). Effect of co-occurring disorders and intimate partner violence on substance abuse treatment outcomes. Journal of Substance Abuse Treatment, 38, 231-244.  
  • Roy-Byrne, P., Joesch, J. M., Wang, P. S., & Kessler, R. C. (2009). Low socioeconomic status and mental health care use among respondents with anxiety and depression in the NCSR. Psychiatric Services, 60(9), 1190-1197.
  • Ouimette, P., Jemelka, R., Hall, J., Krupski, A., & Stark, K. (2007). Services to patients with dual diagnoses: Findings from Washington’s mental health service system. Substance Use and Misuse, 42, 113-127.
  • Ries, R.K. (2006). Co-occurring Alcohol Use and Mental Disorders. Journal of Clinical Psychopharmacology, 26, (6 Suppl 1), S30-36.
  • Comtois, K.A., Tisdall, W.A., Holdcraft, L.C., & Simpson, T.L. (2005). Dual diagnosis: Impact of family history. American Journal on Addictions, 14, 291-299.
  • Ries, R.K., Short, R.A., Dyck, D.G., & Srebnik, D.S. (2004). Unlinking disability income, substance use, and adverse outcomes in dually diagnosed severely mentally ill outpatients. American Journal on Addictions, 13, 390-397.
  • Holdcraft, L.C., & Comtois, K.A. (2002). Description of and preliminary data from a women’s dual diagnosis community health program. Canadian Journal of Community Mental Health, 21, 91-109.
  • Ries, R., Dyck, D., Short, R., Srebnik, D., Snowden, M., & Comtois, K.A. (2002). Use of case manager ratings and weekly urine toxicology tests in among outpatients with dual diagnosis. Psychiatric Services, 53, 764-766.
  • Berry, C, McDonell, M.G., & Dyck, D.G. (2001). Serious emotional disturbance & co-occurrence with poverty, substance abuse, child abuse, and DSM-IV axis II disorders. A report prepared for the Prevalence Advisory Group, Washington State Department of Social and Health Services.
  • Ries, R.K., Russo, J., Wingerson, D., Snowden, M., Comtois, K.A., Srebnik, D., et al. (2000). Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance use disorders. Psychiatric Services, 51, 210-215.
  • Roy-Byrne, P., Pages, K.P., Russo, J.E., Blume, A.W., Jaffe, C., Kingsley, E.L., et al. (2000). Double blind placebo controlled trial of nefazadone in the treatment of major depression in alcohol dependent patients. Journal of Clinical Psychopharmacology, 20, 126-136.
  • Maynard, C., Cox, G.B., Krupski, A., & Stark, K. (1999). Utilization of services for mentally ill chemically abusing patients discharged from residential treatment. The Journal of Behavioral Health Services & Research, 26, 219-228.
  • Ries, R.K., Jaffe, C., Comtois, K., & Mitchell, M. (1999). Treatment satisfaction compared with outcome in severe dual disorders. Community Mental Health Journal, 35, 213-221.
  • Wingerson, D., & Ries, R. (1999). Assertive Community Treatment for patients with chronic and severe mental illness who abuse drugs. Journal of Psychoactive Drugs, 31, 13-18.
  • Jaffe, C., Comtois, K.A., Calsyn, D.A., & Saxon, A.J. (1998). A pilot study comparing severely and persistently mentally ill opiate addicted patients in dual diagnosis treatment in methadone maintenance. American Journal on Addictions, 7, 288-298.
  • McCann, B.S. & Roy-Byrne, P.R. (1998). Attention-deficit/hyperactivity disorder, substance abuse, and post-traumatic stress disorder: A case study with implications for harm reduction. In Session: Psychotherapy in Practice, 4, 53-67.
  • Pirzada, S., Ries, R.K., & LoGerfo, J. (1997). Comorbid cost of alcohol/drug problems on DRG’s. American Journal on Addictions, 6, 193-204.
  • Ries, R., & Comtois, K.A. (1997). Managing disability benefits as part of treatment for persons with severe mental illness and co-morbid drug/alcohol disorders: A comparative study of payee and non-payee participants. The American Journal on Addictions, 6, 330-338.
  • Ries, R., Comtois, K., & Roy-Byrne, P. (1997). Illness severity and treatment services for dually diagnosed severely mentally ill outpatients. Schizophrenia Bulletin, 23, 239-246.
  
);